{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:53:32Z","timestamp":1781654012548,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49619-4","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:04:01Z","timestamp":1776798241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A derivative of PD156707 selectively inhibits NLRP3 inflammasome activation by directly binding to NLRP3"],"prefix":"10.1038","volume":"16","author":[{"given":"Ye-Rin","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Tae","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yong","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Bong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"49619_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz, E., Xiao, T. S. & Stutz, A. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"49619_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P. & Dixit, V. M. Inflammasomes: Mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"49619_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., P\u00e9trilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237 (2006).","journal-title":"Nature"},{"key":"49619_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408 (2011).","journal-title":"Nat. Immunol."},{"key":"49619_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan, Y. et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160, 62 (2015).","journal-title":"Cell"},{"key":"49619_CR6","doi-asserted-by":"crossref","unstructured":"Monnerat, G. et al. Macrophage-dependent IL-1\u03b2 production induces cardiac arrhythmias in diabetic mice. Nat. Commun. 7 (2016).","DOI":"10.1038\/ncomms13344"},{"key":"49619_CR7","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker, N. et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron 110, 2422 (2022).","journal-title":"Neuron"},{"key":"49619_CR8","doi-asserted-by":"publisher","first-page":"12762","DOI":"10.1074\/jbc.M806084200","volume":"284","author":"K Yamasaki","year":"2009","unstructured":"Yamasaki, K. et al. NLRP3\/cryopyrin is necessary for interleukin-1\u03b2 (IL-1\u03b2) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 284, 12762 (2009).","journal-title":"J. Biol. Chem."},{"key":"49619_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo, H., Callaway, J. B. & Ting, N. Y. Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat. Med. 21, 677 (2015).","journal-title":"Nat. Med."},{"key":"49619_CR10","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang, H. et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J. Exp. Med. 214, 3219 (2017).","journal-title":"J. Exp. Med."},{"key":"49619_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll, R. C. et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat. Chem. Biol. 15, 556 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"49619_CR12","doi-asserted-by":"crossref","unstructured":"Marchetti, C. et al. OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc. Natl. Acad. Sci. U. S. A. 115 (2018).","DOI":"10.1073\/pnas.1716095115"},{"key":"49619_CR13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M. S. J. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov. 17, 588 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"key":"49619_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","volume":"91","author":"S Darakhshan","year":"2014","unstructured":"Darakhshan, S. & Pour, A. B. Tranilast: A review of its therapeutic applications. Pharmacol. Res. 91, 15 (2014).","journal-title":"Pharmacol. Res."},{"key":"49619_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2021","unstructured":"Swanson, K. V., Deng, M. & Ting, N. Y. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"49619_CR16","doi-asserted-by":"crossref","unstructured":"Kang, J. et al. Novel activity of ODZ10117, a STAT3 inhibitor, for regulation of NLRP3 inflammasome activation. IJMS. 24 (2023).","DOI":"10.3390\/ijms24076079"},{"key":"49619_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 458, 514 (2009).","journal-title":"Nature"},{"key":"49619_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature10510","volume":"477","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596\u2013600 (2011).","journal-title":"Nature"},{"key":"49619_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1189\/jlb.3HI0316-152R","volume":"102","author":"GM Orlowski","year":"2017","unstructured":"Orlowski, G. M. et al. Frontline science: Multiple cathepsins promote inflammasome-independent, particle-induced cell death during NLRP3-dependent IL-1beta activation. J. Leukoc. Biol. 102, 7\u201317 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"49619_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9, 847\u2013856 (2008).","journal-title":"Nat. Immunol."},{"key":"49619_CR21","doi-asserted-by":"publisher","first-page":"101070","DOI":"10.1016\/j.isci.2020.101070","volume":"23","author":"E Aizawa","year":"2020","unstructured":"Aizawa, E. et al. GSDME-dependent incomplete pyroptosis permits selective IL-1alpha release under caspase-1 inhibition. iScience. 23, 101070 (2020).","journal-title":"iScience"},{"key":"49619_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213\u2013218 (2004).","journal-title":"Nature"},{"key":"49619_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1084\/jem.20172222","volume":"215","author":"D Boucher","year":"2018","unstructured":"Boucher, D. et al. Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J. Exp. Med. 215, 827\u2013840 (2018).","journal-title":"J. Exp. Med."},{"key":"49619_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"W He","year":"2015","unstructured":"He, W. et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion. Cell. Res. 25, 1285\u20131298 (2015).","journal-title":"Cell. Res."},{"key":"49619_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.20151790","volume":"213","author":"FI Schmidt","year":"2016","unstructured":"Schmidt, F. I. et al. A single domain antibody fragment that recognizes the adaptor ASC defines the role of ASC domains in inflammasome assembly. J. Exp. Med. 213, 771 (2016).","journal-title":"J. Exp. Med."},{"key":"49619_CR26","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","volume":"156","author":"A Lu","year":"2014","unstructured":"Lu, A. et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156, 1193\u20131206 (2014).","journal-title":"Cell"},{"key":"49619_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","volume":"45","author":"CJ Gross","year":"2016","unstructured":"Gross, C. J. et al. K(+) efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45, 761\u2013773 (2016).","journal-title":"Immunity"},{"key":"49619_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature16959","volume":"530","author":"Y He","year":"2016","unstructured":"He, Y., Zeng, M. Y., Yang, D., Motro, B. & Nunez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354\u2013357 (2016).","journal-title":"Nature"},{"key":"49619_CR29","doi-asserted-by":"crossref","unstructured":"Shi, H. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. (2015).","DOI":"10.1038\/ni.3333"},{"key":"49619_CR30","doi-asserted-by":"crossref","unstructured":"Pai, M. Y. et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol. Biol. 287 (2016).","DOI":"10.1007\/978-1-4939-2269-7_22"},{"key":"49619_CR31","doi-asserted-by":"crossref","unstructured":"Patil, S. M. et al. Computational screening of benzophenone integrated derivatives (BIDs) targeting the NACHT domain of the potential target NLRP3 inflammasome. Adv. Cancer Biol. Metastasis 5 (2022).","DOI":"10.1016\/j.adcanc.2022.100056"},{"key":"49619_CR32","doi-asserted-by":"crossref","unstructured":"Fu, J. & Wu, H. Structural mechanisms of NLRP3 inflammasome assembly and activation. (2023).","DOI":"10.1146\/annurev-immunol-081022-021207"},{"key":"49619_CR33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41586-022-05570-8","volume":"613","author":"L Xiao","year":"2024","unstructured":"Xiao, L., Magupalli, V. G. & Wu, H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature 613, 595 (2024).","journal-title":"Nature"},{"key":"49619_CR34","doi-asserted-by":"crossref","unstructured":"Hayat, C. et al. Identification of new potent NLRP3 inhibitors by multi-level in-silico approaches. BMC Chem. 18 (2024).","DOI":"10.1186\/s13065-024-01178-3"},{"key":"49619_CR35","doi-asserted-by":"crossref","unstructured":"Liu, D. & Huang, Y. Protocol for in vivo and in vitro activation of NLRP3 inflammasome in mice using monosodium urate. STAR Protoc. 4 (2023).","DOI":"10.1016\/j.xpro.2023.102554"},{"key":"49619_CR36","doi-asserted-by":"crossref","unstructured":"Kannan, S. K. et al. Mouse models of sepsis. Curr. Protoc. 4 (2024).","DOI":"10.1002\/cpz1.997"},{"key":"49619_CR37","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666\u2013671 (2015).","journal-title":"Nature"},{"key":"49619_CR38","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/eji.201545772","volume":"45","author":"S Ruhl","year":"2015","unstructured":"Ruhl, S. & Broz, P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur. J. Immunol. 45, 2927\u20132936 (2015).","journal-title":"Eur. J. Immunol."},{"key":"49619_CR39","doi-asserted-by":"publisher","first-page":"100924","DOI":"10.1016\/j.mam.2020.100924","volume":"76","author":"KP Downs","year":"2020","unstructured":"Downs, K. P., Nguyen, H., Dorfleutner, A. & Stehlik, C. An overview of the non-canonical inflammasome. Mol. Aspects Med. 76, 100924 (2020).","journal-title":"Mol. Aspects Med."},{"key":"49619_CR40","doi-asserted-by":"crossref","unstructured":"El-sayed, S., Freeman, S. & Bryce, R. A. Probing the effect of NEK7 and cofactor interactions on dynamics of NLRP3 monomer using molecular simulation. Protein Sci. 31 (2022).","DOI":"10.1002\/pro.4420"},{"key":"49619_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","volume":"75","author":"Q Ma","year":"2023","unstructured":"Ma, Q. Pharmacological inhibition of the NLRP3 inflammasome: Structure, molecular activation, and inhibitor-NLRP3 interaction. Pharmacol. Rev. 75, 487 (2023).","journal-title":"Pharmacol. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49619-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49619-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49619-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:06:07Z","timestamp":1781651167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49619-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49619"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49619-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18577"}}